Estimating a cost-effectiveness threshold for health care decision-making in South Africa-a Commentary

Health Policy Plan. 2022 Sep 13;37(8):1066-1069. doi: 10.1093/heapol/czac026.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anti-HIV Agents*
  • Cost-Benefit Analysis
  • Delivery of Health Care
  • Humans
  • Quality-Adjusted Life Years
  • South Africa

Substances

  • Anti-HIV Agents